lutetium has been researched along with Cancer of Esophagus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, GI; Kang, JH; Kim, KI; Lee, BC; Lee, HW; Lee, JS; Lee, TS; Lee, YJ; Lim, SM; Moon, BS; Park, YS; Song, IH | 1 |
1 other study(ies) available for lutetium and Cancer of Esophagus
Article | Year |
---|---|
Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Chelating Agents; Copper Radioisotopes; ErbB Receptors; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Lutetium; Positron Emission Tomography Computed Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2016 |